Bluish or grey lips, fatigue, breathlessness, heart murmur, and irregular heartbeat may signal Ebstein’s anomaly—a rare ...

Opens in a new tab or window Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will cover the procedure when used for an FDA ...

A postnatal examination showed severe tricuspid valve regurgitation and heart failure ... exclusion of other causes of atrial enlargement, such as Ebstein anomaly, tricuspid stenosis, pulmonary ...

The US Centers for Medicare & Medicaid Services (CMS) has finalized its national coverage determination (NCD) for transcatheter tricuspid valve replacement (TTVR) when used to treat patients with ...

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of symptomatic tricuspid regurgitation. The procedures will be subject to ...

The company develops a prosthetic valve device designed to improve the quality of life for those with tricuspid regurgitation (TR). Delivered through a minimally invasive procedure, the valve ...

Laplace Interventional’s device aims to offer an improvement to the quality of life to patients worldwide diagnosed with Tricuspid Regurgitation (TR). Laplace Interventional is developing a prosthetic ...

MagNav.jl contains a full suite of tools for airborne Magnetic anomaly Navigation (MagNav), including flight path & INS data import or simulation, mapping, aeromagnetic compensation, and navigation.

Congenital heart disease (CHD) is a variety of structural and functional abnormalities in the heart that are present at birth. These conditions can affect the heart's chambers, valves, or blood ...